Thu, Aug 21, 2014, 3:31 PM EDT - U.S. Markets close in 29 mins.

Recent

% | $
Quotes you view appear here for quick access.

XOMA Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stpetebum stpetebum Nov 20, 2012 7:33 AM Flag

    Acne trial still recruiting

    GF get a modicum of reality in your investing. When originally announced, they were suppossed to have the study completed by Dec- Now they are " still recruiting" for a study that is only 84 days. Something seems amiss if they can't find a few hundred teen-boppers with bad acne in a year. I would like to know if they run the studies themselves or farm them out to a CRO. anyone know? They seem to have some difficulty in reliably reporting the progress of the trials. Rember they said they had started to enroll the uveitis DJD studies the end of June , never showed up in clinicaltrials.gov for several months, then they announced they were starting enrollment a few months ago/ What gives. If they can't find a few hundred kids with acne, how they gonna find 10 with Sweet's syndrome ( neutrophilic Dermatoses?)One ANALyst put it well a few years ago- Xoma-long on hype, short on delivery Just opinion

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • St. Pete,
      I am shocked at your latest post. Please correct me if I am wrong, but when I just checked clinical trials dot gov for xoma's vulgaris trial, the last update and verification was June 2012. How do you know any different?

      I posted this before but let me give you the hints again so you can find the website. Her name is Kim Townsend-Jones and she runs a Sweets Syndrome Support Site. There is a list of about 65 people. Some are from outside the u.s. but a lot are in the u.s.. Certainly a lot more than 10.

      Can we get back on track with reality? I have ALWAYS regarded your comments as fair but this latest one just doesn't seem to have the veracity I have always associated with you.

    • BTW, clinicaltrials.gov shows that Perindopril Amlodipine trial for the Treatment of Hypertension (PATH) is still ongoing although yesterday PR stated that it has been completed. Same could be for acne trial.

    • Pete you'd think it would be apparent if it's going to work or not wouldn't you? I mean either your zits go away or they don't, it's there for everyone to see. And this isn't an investment it's a gamble!!!

      Sentiment: Strong Buy

 
XOMA
4.2021-0.0879(-2.05%)3:29 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.